There’s some positive news concerning an experimental vaccine for the coronavirus.
Drugmaker Moderna has announced that all of their participants in a stage 1 trial produced antibodies for COVID-19 after receiving two doses of its mRNA vaccine.
There’s some positive news concerning an experimental vaccine for the coronavirus.
Drugmaker Moderna has announced that all of their participants in a stage 1 trial produced antibodies for COVID-19 after receiving two doses of its mRNA vaccine.